Consumer healthcare firm Haleon has revealed a surprise dip in revenues for the latest quarter as it was impacted by weaker ...

Haleon posted an unexpected drop in third-quarter revenue, hurt by a weak demand for its painkiller in Australia and the Middle East.

In the three months ended 30 September, 2024, it achieved organic revenue and organic profit growth of 6.1 per cent and 7.4 ...

It said its biggest brands helped drive a 5.4% rise in organic revenues, highlighting particularly strong performances from Sensodyne, Parodontax and Advil. Meanwhile, organic profits grew by 7.4% ...

Haleon PLC on Thursday noted a small decline in revenue led by Digestive Health, while its Oral Health products enjoyed popularity. The Weybridge, Surrey-based consumer healthcare firm said organic ...

Haleon (HLN) share price has retreated in the past few weeks, erasing some of the gains made earlier this year. Its London ...

Currency fluctuations meant Haleon saw year-on-year reported revenue slip 0.6% to £2.78bn in the third quarter, below ...

Detailed price information for Biontech Se ADR (BNTX-Q) from The Globe and Mail including charting and trades.

parodontax, a brand of oral health products, used a three-prong consistent campaign over seven years to raise awareness of gum disease and to position its toothpaste optimised for gum health as the ...

Haleon reported organic revenue growth of 6.1% for the third quarter on Thursday, driven by balanced increases in both price and volume/mix at 3.3% and 2.8% respectively, though reported revenue ...